Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Headquarters Address, Phone Number, Investor Relations Contacts and More

Regeneron Pharmaceuticals, Inc. as the name suggests is a trusted and leading biotechnology company. The headquarters of Regeneron Pharmaceuticals is located in Westchester County, New York. Regeneron Pharmaceuticals was incorporated in 1988 and is currently under execution of its CEO Leonard Schleifer.

Are you interested in Regeneron Pharmaceuticals Stocks? If yes, then surely this piece of information may interest you- Regeneron Pharmaceuticals is a listed company and its stocks can be followed at NASDAQ with stock name REGN. Regeneron Pharmaceuticals is also a part of NASDAQ-100 component and S&P 500 component index. Further more, in this article you can refer contact information of Regeneron Pharmaceuticals including Headquarters address, media inquiries, investor relations, customer support, location info and more.

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Image Credit: Westfair Online

Regeneron Pharmaceuticals Headquarters Information

The headquarters of Regeneron Pharmaceuticals is established in a big building structure located in New York. Here we have mentioned the full Headquarters Address info for those who wish to communicate with Regeneron Pharmaceuticals Headquarters Officials please take a note of the Regeneron Pharmaceuticals Headquarters Address : 777 Old Saw Mill River Road Tarrytown, NY 10591.

You may also get in touch with Regeneron Pharmaceuticals Headquarters Officers on phone, please take a note of the Corporate Phone Number: +1 914-847-7000.

Media Inquiries Email and Phone

Here we have listed the Media Relations contact info of Regeneron Pharmaceuticals for the use of Media Professionals. For media inquiries Regeneron Pharmaceuticals Media Relations can be contacted at their Medical Inquiry Phone Line: 1-844-REGN-MID (1-844-734-6643).

You can also send in your media inquiries at their email address, please write to them at Media Relations Email Address: media@regeneron.com.

Customer Call Center

If you need to contact Regeneron Pharmaceuticals Customer Care team for information or queries related to Regeneron Pharmaceuticals, you can contact them at Regeneron Pharmaceutical  Customer Call Center. Please note down the contact number of Customer Care Call Center: +1 914-847-7000.

Investor Relations Email and Phone

For investment inquiries, Regeneron Pharmaceuticals Investor Relations team can be contacted. You may share your investment related inquiries on their official phone number: 914.847.7741.

For emails regarding similar concerns or queries, please send it at Regeneron Pharmaceuticals Investor Relations Email Address: invest@regeneron.com.

Medical Information Department Contact

To contact Medical Information Department, you can call at 1-855-REGEN-4-U (1-855-734-3648).  You can use the given contacts if you are a Healthcare professionals, Patients or Caregivers and need any specific information about Regeneron products. You may also contact the concerned department to report an adverse event or to file product complaint. regarding Regenron products.

Regeneron Pharmaceuticals Office Locations in USA

Here we have mentioned the contact information of Regeneron Pharmaceuticals Office locations based out in USA. Please refer the details here:

  • You can contact Basking Ridge (Clinical Operations & Biostats) at their Office Address: 110 Allen Road Basking Ridge, NJ 07920 or
    Phone Number: +1 914-847-7000.
  • To contact Industrial Operations and Product Supply office, please contact at this Address: 81 Columbia Turnpike Rensselaer, NY 12144 or call at Phone Number: +1 518-488-6000.
  • For Washington, DC Office, contact at this address: 1399 New York Avenue, NW 10th Floor Washington, DC 20005 or call at their Phone Number: +1 914-598-3031.

Also, you can visit Regeneron Official Website, this is the link: https://www.regeneron.com/ for more information and updates.

Also Read:  Gilead Sciences Headquarters Address

Article last re-published on March 4, 2021.